2. Ranbaxy slowest in growth
despite boosting sales team s
The country’s largest drugmaker by revenues has
recorded the slowest domestic sales growth rate
among its peers in the first seven month of this year,
despite boosting its sales force by over 50%.
For August alone, Ranbaxy was also the only
company among the top 15 drugmakers to register a
single digit growth of 7.4%, less than half the
industry growth of 17.4%, (IMS Health).
Japan’s Daiichi Sankyoowned drugmaker has
rejected IMS retail sales numbers. For the year to
date period, Ranbaxy’s sales growth (company’s
internal sales data) has been over 16% and in
particular, has demonstrated a healthy acceleration
in last three months to 20% plus.
3. Indian cos see red over lal dant
manjanpatent
Lal dant manjan, or ‘red herbal dentifrice’,
is now patented in the US by Colgate
Palmolive, and Indian ayurvedic companies
have sought government intervention to
cancel it.
The Association of Manufacturers of
Ayurvedic Medicines (Amam), has accused
the American personal care giant of
patenting an Indian traditional knowledge in
the US, India and elsewhere.
4. Control redefinition to check
indirect hold over Indian cos
The government will make it tough for foreign
firms to exercise control over Indian
businesses though indirect arrangements by
updating the ambiguous definition of ‘control’
in foreign direct investment policy with the
precise one used in the Companies Bill.
The current foreign investment policy says any
Indian company ‘owned or controlled’ by a
foreign company would be considered a
foreign company.
While a more than 50% equity holding was
sufficient for establishing foreign ownership.
5. Jaguar Land Rover launches
armoured vehicles priced at
Rs 4.75 crore
Jaguar Land Rover launched the armoured
range of its Range Rover and Discovery
sports utility vehicles, with indicative prices
of Rs 4.75 crore and Rs 3.75 crore
respectively.
The armoured vehicles market is a very
niche segment and we don't want to leave
it out. We are launching these vehicles in
India so that we have the complete range
of offering here," Tata Motors.
6. Wipro admits to performing
lower than TCS, Infy
India's third largest IT bellwether Wipro Ltd
on Friday admitted that its performance
during the second quarter (July-Sept) of
this fiscal was lower than industry peers
TCS and Infosys Technologies sequentially
and annually.
Tata Consulting Service (TCS) reported a
record 11 per cent volume growth on
second quarter and 7.2 per cent by Infosys
Technologies a week ago, Wipro reported
6.6 per cent only.
7. No import levy on power parts:
Finmin
The finance ministry has shot down a proposal
to levy 20% duty on imported power
equipment.
Domestic capacity was far short of demand
and the proposed move have made electricity
more costly.
Local equipment suppliers, led by BHEL, are
struggling to meet the huge demand from
power firms, which are building new capacity
of about 80,000 MW in the Eleventh Plan that
ends in 2012.